Breast cancer imaging: the future.
Imaging technology has changed rapidly over the last four decades. This is especially true in the area of breast cancer. While anatomic delineation of breast tumors was considered a crowning achievement of the late 20th century, most recently the major focus has shifted toward physiologic and even molecular level tumor detection. The goals of imaging are threefold: (1) the earliest possible detection of primary breast tumors, (2) correlation of imaging results with other clinical parameters to assess disease biology, and (3) accurate staging and follow-up after treatment. Among the newer imaging technologies to be discussed here are digital mammography, computer-aided diagnosis (CAD), power Doppler ultrasound, magnetic resonance imaging (MRI), isotope imaging: methoxyisobutyl-isonitrile (MIBI) and positron emission tomography (PET). Semin Oncol 28:221-228.
Jochelson
M
M
San Fernando Valley Women's Center, 18344 Clark St., Suite 110, Tarzana, CA 91356, USA.
D001943:Breast Neoplasms / Q000175:diagnosis*; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods / Q000639:trends*; D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi; D014055:Tomography, Emission-Computed / Q000379:methods / Q000639:trends; D014463:Ultrasonography / Q000379:methods / Q000639:trends*
D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi